The experimental toxicology of tramadol: An overview

Toxicology Letters

Volumn 95, Issue 1, 1998, Pages 63-71

  Matthiesen, T ^a   Wohrmann T ^a   Coogan, T P ^b   Uragg, H ^a  

^a GRÜNENTHAL GMBH   (Germany)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

Analgesic; Review; Toxicology; Tramadol

Indexed keywords

ANALGESIC AGENT; TRAMADOL;

ACUTE TOXICITY; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CHRONIC TOXICITY; CONVULSION; DEATH; FEMALE; GAIT DISORDER; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LD 50; LIVER TUMOR; LUNG TUMOR; MALE; MOUSE; MUTAGENICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECTAL DRUG ADMINISTRATION; RESTLESSNESS; SUBCUTANEOUS DRUG ADMINISTRATION; TOXICITY TESTING; TOXICOKINETICS; VOMITING;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; CARCINOGENICITY TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LETHAL DOSE 50; MALE; MUTAGENICITY TESTS; REPRODUCTION; STEREOISOMERISM; TRAMADOL;

EID: 0032584041     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00023-X     Document Type: Article

References (16)

1. Bomhard, E., 1993. Frequency of spontaneous tumours in NMRI mice in 21-month studies. Exp. Toxicol. Pathol. 45, 269-289.
2. Bomhard, E., Mohr, U., 1989. Spontaneous tumours in NMRI mice from carcinogenicity studies. Exp. Pathol. 36, 129-145.
3. Erlaçin, S., Frankus, E., Lintz, W., 1980. Metabolism of tramadol in man and animals. Naunyn-Schmiedeberg's Arch. Pharmacol. 313 (Suppl), R51.
4. Frink, M.C., Hennies, H.H., Englberger, W., Haurand, M., Wilffert, B., 1996. Influence of tramadol on neurotransmitter systems of the rat brain. Arzneim.-Forsch./Drug Res. 46, 1029-1036.
5. Kaspareit, J., Deerberg, F., 1987. Tumour incidence and tumour spectrum of male Han:NMRI mice. Z. Versuchslierkd. 30, 105-109.
6. Kato, R., Kamataki, T., 1982. Cytochrome P-450 as a determinant of sex difference drug metabolism in the rat. Xenobiotica 12, 787-800.
7. Lagler, F., Helm, F., Etzel, V., Kiel, H., 1978. Toxicological study on tramadol, a new analgetic agent. Arzneim.-Forsch./Drug Res. 28, 164-172.
8. Lintz, W., 1980. Pharmacokinetics of tramadol in man and animals. Naunyn.-Schmiedeberg's. Arch. Pharmacol. 313 (Suppl), R53.
9. Lintz, W., Erlaçin, S., Frankus, E., Uragg, H., 1981. Biotransformation of tramadol in man and animals. Arzneim.-Forsch./Drug Res. 31, 1932-1943.
10. Raffa, R.B., Friderichs, E., Reimann, W., Shank, R.P., Codd, E.E., Vaught, J.L., 1992. Opoid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid. J. Pharmacol. Exp. Ther. 260, 275-285.
11. Raffa, R.B., Friderichs, E., Reimann, W., Shank, R.P., Codd, E.E., Vaught, J.L., Jacoby, H.I., Selve, N., 1993. Complementary and synergistic antinoceptive interaction between the enantiomers of tramadol. J. Pharmacol. Exp. Ther. 267, 331-340.
12. Rehm, S., Rapp, K.G., Deerberg, F., 1985. Influence of food restriction and body fat on lifespan and tumour incidence in female outbred Han:NMRI mice and two sublines. Z. Versuchstierkd. 27, 249-283.
13. Research & Consulting Company AG (RCC), 1990. Historical data on tumor incidence in control NMRI-mice (terminal sacrifice group animals). Issued by RCC, Itingen, Switzerland.
14. Stölzer, H., Notman, J., 1981. Bedeutung spontan auftretender Tumoren bei Mäusen (Importance of spontaneously occurring tumours in mice). AMI Reports 2/1981. Dietrich Reimer, Berlin.
15. Takacs, A.R., 1995. Ancillary approaches to toxicokinetic evaluations. Toxicol. Pathol. 23, 179-186.
16. Weisse, I., Köllmer, H., Tilov, T., Stolzer, H., 1975. Spontantumoren bei einem NMRI-Mäuse-Auszuchtstamm (Spontaneous tumours in a strain of NMRI/non-inbred mice). Z. Versuchstierkd. 17, 91-98.